This classic resource by Drs. Mitchel P. Goldman, Robert A Weiss, and Jean-Jerome Guex provides highly practical, up-to-date guidance for the effective management of varicose veins and other vascular anomalies. It is an indispensable reference for a wide audience including dermatologists, invasive radiologists, family practitioners, vascular and cosmetic surgeons. Clearly written by global experts, Sclerotherapy, 6th Edition, helps those new to the field to gain a firm understanding of successful techniques, as well as showing seasoned practitioners how to improve and hone their skills with today's best and newest approaches. Case studies and detailed color illustrations offer step-by-step visual guidance. - Covers everything you need to know with a practical approach, from the pathogenesis of varicosities to diagnostic and treatment options, including evidence-based decision making. - Helps you optimize outcomes and improve your surgical, injection, and laser techniques with comprehensive, visual guidance, including coverage of common pitfalls and "tricks of the trade." - Consult this title on your favorite e-reader, conduct rapid searches, and adjust font sizes for optimal readability. - Features hot topic coverage of endovenous glue and new endovenous ablation techniques, as well as updated techniques for optimal use of foam sclerotherapy and uses for solutions recently available on the market. - Discusses new concepts for treating areas other than the legs, including rejuvenation of the hands and chest.
The purpose, of writing this book, is to provide a self-contained primer, workbook and reader for teaching first-year Sanskrit students with no previous linguistic training. The author has tried throughout the work to introduce, explain and illustrate the most significant features of the language and through verses, quotations, and readings. To these ends, the grammar has been, in several areas, simplified to prevent the beginner from being more hampered than is absolutely necessary by relatively insignificant paradigms, rules and exceptions. Upon completion of this course, students should have a real working knowledge of the major outlines of Sanskrit sentences with some facility and read, with the help of a dictionary, approximately five to ten verses of the Valmiki Ramayana or a similar text in an hour. For more information, please head to www.mlbd.co.in
Blind Realism originated in the deeply felt conviction that the widespread acceptance of Gettier-type counterexamples to the classical definition of knowledge rests in a demonstrably erroneous understanding of the nature of human knowledge. In seeking to defend that conviction, Robert F. Almeder offers a fairly detailed and systematic picture of the nature and limits of human factual knowledge.
The complete guide to venous disease diagnosis and treatment, both medical and surgical Includes procedure tutorial on DVD! Widely acclaimed in its first edition, Sclerotherapy and Vein Treatment, 2e spans the entire scope of diagnosing and treating varicose and telangiectatic veins. Reflecting both medical and surgical alternatives, this comprehensive, yet practical, guide offers cutting-edge insights from some of the world’s most prominent experts on the management of venous disease. You will find step-by-step procedural guidance, supported by hundreds of superb full-color illustrations that add clarity to the text and depict the techniques of successful cannulation. Features: Provides a hands-on overview of medical and surgical techniques Covers the latest advances, including new diagnostic technologies, micro-phlebectomy, foam sclerotherapy, and lasers and high intensity pulsed light Includes contraindications, difficult problems, complications, and case studies of common problems
“All of our working lives we have heard the mantra, ‘a reputation lost is never regained.’ Still, the firms we work for, admire and invest in seem to take costly reputation hits all too often. Everyone interested in managing, regulating or investing in public firms will find Nir Kossovsky’s book a wonderful read through reputations won, lost and regained over the last 20 years. This is the first book which goes beyond platitudes to explain how to spot value-destroying reputation risk and how to manage it or live with its consequences. Couldn't be more timely.” —Tom Skwarek, Managing Director|Structuring and Solutions Group, Unicredit Bank AG; previously Managing Director|Corporate Strategic Solutions, Swiss Re. “There are fiduciary reasons why corporate directors would benefit from reading this book. There is also a personal benefit. The collapse of a company’s reputation can stain the personal reputation of its directors.” —George Miles, Member of the Board of Directors, AIG, EQT, Harley Davidson, HFF, and Wesco. “Nir Kossovsky has written a gripping tale, first educating the reader by distinguishing between corporate branding and reputation, then alarming us with case histories of mismanagement of corporate reputational crises, and finally reassuring all with a unique solution, i.e., insuring against the risk of reputational loss.” —John H. Bennett, Partner, Global Brand Positioning, previously Chief Marketing Officer, Visa, Inc. “While directors know reputation is important, it often is treated as a vague ‘good’ until something bad happens. Nir Kossovsky does a great job, with many examples, of connecting reputation to stock price and to behaviors, before and after crises. If you are a director, a senior manager, or a regulator, you should read this book and remember the lessons it offers. There is no office which will restore reputation, but careful planning and quick response, as Nir points out, can make a big difference.” —Herbert S. Winokur, Jr., former chairman on Enron’s Board Finance Committee and a director of many for-profits and non-profits A company that takes a hit to its reputation—BP after the Gulf oil spill, Barclays after fiddling LIBOR, News Corp after the phone hacking scandal—enters a world of grief: market value falls along with employee morale, regulatory scrutiny increases, and customers defect and boycott. Reputation, Stock Price, and You: Why the Market Rewards Some Companies and Punishes Others shows how a company’s reputation is created and how reputational value impacts corporate P&L and the personal finances of its many stakeholders. Better yet, it shows what you can do to profit from, increase, protect, monitor, evaluate, restore, and even insure reputational value. If your job, bonus, options, salary, or investments depend on the stock price of a public company—or on the sales, profitability, or value of a private company—you need to read this book to understand the concrete steps you can take to improve your firm’s reputation, reduce risks to its finances and industry standing, and reap the highest reputational dividends. Using dozens of case studies, Reputation, Stock Price, and You: Explains how stakeholders, and their expectations, both shape and are shaped by a company’s reputation Describes how reputations for ethics, innovation, good governance, quality, safety, sustainability, and security are created and lost Explains why both corporate and individual stakeholder behavior affect reputational value Shows how you can influence the expectations and behaviors of stakeholders, which in turn can improve corporate finances, reduce operational risk, and increase stock price or market value Provides sensitive tools for tracking and predicting stock price as a function of reputational value metrics The majority of directors at U.S. public companies now count reputation as their firm’s #1 concern, and with good reason. A firm with a superior reputation gains many benefits: Customers are more willing to pay higher prices, vendors and employees offer better terms for their services, creditors and equity investors offer better terms for capital, and regulators tend to be more forgiving. This book shows how to achieve and sustain a stellar reputation and how to convert it into its tangible form: reputational value.
THE SECRETS TO CAPITALIZING ON THE COMMODITIES BOOM In the mid-1970s, when Bob Greer scrolled through miles of microfilm in the basement of a public library in order to record commodity prices in his yellow legal pad, the idea of commodities being an investable asset class was way outside the mainstream. Now, it's a multibilliondollar vehicle for achieving portfolio diversification and inflation hedging--and he and his colleagues have written the book on earning better returns than the indexes themselves! In Intelligent Commodity Indexing, Bob joins his fellow leaders of PIMCO's Commodity Practice, Nic Johnson and Mihir Worah, in opening up commodity indexes. Never before has there been a more thorough explanation of how a commodity index works coupled with a powerful set of strategies for making it work for you. Inside, you'll find the most up-to-date tools and time-proven best practices for earning "structural alpha" by capitalizing on recurring risk and liquidity premiums in the commodities markets. It offers the right amount of history and theory to reinforce cuttingedge techniques for: Interpreting how seasonal effects change risk premia Choosing the most profitable market for specific commodity exposure Using intelligent commodity indexing to collect risk premiums in the options market Maximizing roll yield in order to increase long-term returns Managing risk, including specific frameworks and systems Investors gain a superior advantage with this book's coverage of the nuts-and-bolts workings of various markets. Praise for Intelligent Commodity Indexing "A seminal work on an asset class that has grown in importance within institutional portfolios. The authors offer considerable insight to this complex asset class and provide investors with a thorough examination of the drivers of risk and return." -- Julia K. Bonafede, CFA, President of Wilshire Consulting "This is an excellent guide for professional investors to successful investing in commodity indexes." -- Blythe Masters, Head of Global Commodities, JP Morgan "A manual written by successful practitioners for intelligent commodity investors. An excellent guide which explains how this asset class complements and interacts with other investments." -- Alan H. Van Noord, CFA, Chief Investment Officer, Pennsylvania Public School Employees' Retirement System "Commodities are invaluable tools for investors wishing to benefit from diversification and inflation hedging. For such an investor, this is the authoritative source to all you need to know about commodity indexing." -- Mark Makepeace, Chief Executive, FTSE Group "Greer, Johnson, and Worah simply explain the critical drivers to commodity index returns that have provided the main historical benefits of diversification and inflation protection. Every commodity index investor, or hopeful investor, should read this book and use it as a guide for evaluating the relevant index characteristics for benchmarking and investing, especially given recent industry innovations." -- Jodie Gunzberg, CFA, Director-Commodities, S&P Indexes
Part of the highly popular Practical Approach to Anesthesia series, this new edition combines the comprehensive depth of a textbook and the user-friendly features of a practical handbook. Focusing on clinical issues in pediatric anesthesia, it contains the in-depth information you need for daily practice and study, presented in a concise, bulleted format for quick reference. With its emphasis on developmental aspects of pediatric anesthesia, numerous illustrations and tables, and methodical approach to decision making, this updated reference is an invaluable resource for anyone involved with anesthesia of children.
Scientific naturalism, or scientism, is the theory that science has all the answers. This book argues that not all philosophical explanations can be reduced to scientific ones. Refuting support for scientism, it suggests that reliabilist and causal theories of epistemic justification are unsound.
An Essential Guide to the Processes and Operational Complexities of the U.S. Healthcare System The U.S. Healthcare Ecosystem serves as an expert navigator through the complicated and often confusing environment where healthcare payers, healthcare providers, and producers of healthcare technologies all interact. This thorough resource provides expert insight and analysis of employer-based health insurance, pharmacy benefits, the major professions, healthcare consolidation, drug discovery and development, biotechnology, and much more. Packed with timely examples and filled with illustrations, The U.S. Healthcare Ecosystem will inspire you to think more critically about the business of healthcare and make informed assessments. Features: Includes often neglected topics impacting healthcare delivery such as employer-based health insurance, pharmacy benefits, healthcare consolidation, and biotechnology Highly readable and single-authored by a Wharton Professor who has taught health care delivery and management for over 20 years Filled to the brim with helpful diagrams, charts and tables - nearly 350 figures complement the text Every chapter ends with a helpful Summary and Questions to Ponder
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.